A fantastic series by Aditya Chakrabortty on Boots. He carefully documents the ways in which Boots not only profits from general NHS prescriptions (fair enough) but how it has taken advantaged of other schemes that are used to extract additional profits from the NHS.
In particular, Chakrabortty suggests that Boots pressures managers to provide medicine-use-reviews (MURs) to customers that didn’t need them. Each MUR provided brings in £28 from the NHS to the pharmacist – in this case Boots.
You can read a follow-up piece and letters from whistle blowers here